The Enterprise Value as of November 2024 (TTM) for Applied DNA Sciences, Inc. (APDN) is -1749572.00

According to Applied DNA Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -1749572.00. This represents a change of -149.46% compared to the average of 3.54M of the last 4 quarters.

Applied DNA Sciences, Inc. (APDN) Historical Enterprise Value (quarterly & annually)

How has APDN Enterprise Value performed in the past?

The mean historical Enterprise Value of Applied DNA Sciences, Inc. over the last ten years is 41.55M. The current -1749572.00 Enterprise Value has changed -521.04% with respect to the historical average. Over the past ten years (40 quarters), APDN's Enterprise Value was at its highest in in the June 2022 quarter at 127.90M. The Enterprise Value was at its lowest in in the June 2024 quarter at -7386277.75.

Applied DNA Sciences, Inc. (APDN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Applied DNA Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Applied DNA Sciences, Inc. (APDN) Average Enterprise Value

How has APDN Enterprise Value performed in the past?

The current Enterprise Value of Applied DNA Sciences, Inc. (APDN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Applied DNA Sciences, Inc. (APDN) Enterprise Value vs. Peers

How is APDN’s Enterprise Value compared to its peers?

Applied DNA Sciences, Inc.’s Enterprise Value is less than Biodesix, Inc. (216.75M), less than DarioHealth Corp. (59.29M), less than Olink Holding AB (publ) (3.16B), less than Genetron Holdings Limited (0), less than Exagen Inc. (73.55M), greater than Burning Rock Biotech Limited (-29410816.44), less than Neuronetics, Inc. (54.69M), less than Sera Prognostics, Inc. (212.96M), less than OncoCyte Corporation (46.25M), less than Personalis, Inc. (204.95M), less than Interpace Biosciences, Inc. (10.79M), less than iSpecimen Inc. (3.71M), less than Trinity Biotech plc (107.59M), less than Mainz Biomed B.V. (12.42M), less than Prenetics Global Limited (15.16M), less than FONAR Corporation (90.09M),

Build a custom stock screener for Applied DNA Sciences, Inc. (APDN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied DNA Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Applied DNA Sciences, Inc. (APDN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Applied DNA Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.